Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Publisher Correction: Sarcoidosis.

Grunewald J, Grutters JC, Arkema EV, Saketkoo LA, Moller DR, Müller-Quernheim J.

Nat Rev Dis Primers. 2019 Jul 16;5(1):49. doi: 10.1038/s41572-019-0107-y.

PMID:
31311930
2.

Sarcoidosis.

Grunewald J, Grutters JC, Arkema EV, Saketkoo LA, Moller DR, Müller-Quernheim J.

Nat Rev Dis Primers. 2019 Jul 4;5(1):45. doi: 10.1038/s41572-019-0096-x. Review. Erratum in: Nat Rev Dis Primers. 2019 Jul 16;5(1):49.

PMID:
31273209
3.

Sarcoidosis and Work Participation: The Need to Develop a Disease-Specific Core Set for Assessment of Work Ability.

Hendriks CMR, Saketkoo LA, Elfferich MDP, De Vries J, Wijnen PAHM, Drent M.

Lung. 2019 Aug;197(4):407-413. doi: 10.1007/s00408-019-00234-3. Epub 2019 May 17.

4.

Results from an American pilot survey among Scleroderma Clinical Trials Consortium members on capillaroscopy use and how to best implement nailfold capillaroscopy training.

Snow MH, Saketkoo LA, Frech TM, Stever JR, Lebedoff N, Herrick AL, Cutolo M, Smith V.

Clin Exp Rheumatol. 2019 Apr 5. [Epub ahead of print] No abstract available.

PMID:
31025929
5.

Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study.

Elhai M, Boubaya M, Distler O, Smith V, Matucci-Cerinic M, Alegre Sancho JJ, Truchetet ME, Braun-Moscovici Y, Iannone F, Novikov PI, Lescoat A, Siegert E, Castellví I, Airó P, Vettori S, De Langhe E, Hachulla E, Erler A, Ananieva L, Krusche M, López-Longo FJ, Distler JHW, Hunzelmann N, Hoffmann-Vold AM, Riccieri V, Hsu VM, Pozzi MR, Ancuta C, Rosato E, Mihai C, Kuwana M, Saketkoo LA, Chizzolini C, Hesselstrand R, Ullman S, Yavuz S, Rednic S, Caimmi C, Bloch-Queyrat C, Allanore Y; for EUSTAR network.

Ann Rheum Dis. 2019 Jul;78(7):979-987. doi: 10.1136/annrheumdis-2018-214816. Epub 2019 Apr 9.

PMID:
30967395
6.

Use of red cell distribution width in a population at high risk for pulmonary hypertension.

Petrauskas LA, Saketkoo LA, Kazecki T, Saito S, Jaligam V, deBoisblanc BP, Lammi MR.

Respir Med. 2019 Apr;150:131-135. doi: 10.1016/j.rmed.2019.03.003. Epub 2019 Mar 16.

PMID:
30961939
7.

Microparticles in systemic sclerosis: Potential pro-inflammatory mediators and pulmonary hypertension biomarkers.

Lammi MR, Saketkoo LA, Okpechi SC, Ghonim MA, Wyczechowska D, Bauer N, Pyakurel K, Saito S, deBoisblanc BP, Boulares AH.

Respirology. 2019 Jul;24(7):675-683. doi: 10.1111/resp.13500. Epub 2019 Feb 12.

8.

Risk Factors for Mortality and Cardiopulmonary Hospitalization in Systemic Sclerosis Patients At Risk for Pulmonary Hypertension, in the PHAROS Registry.

Hsu VM, Chung L, Hummers LK, Shah A, Simms R, Bolster M, Hant FN, Silver RM, Fischer A, Hinchcliff ME, Varga J, Goldberg AZ, Derk CT, Schiopu E, Khanna D, Shapiro LS, Domsic RT, Medsger T, Mayes MD, Furst D, Csuka ME, Molitor JA, Saketkoo LA, Salazar CR, Steen VD.

J Rheumatol. 2019 Feb;46(2):176-183. doi: 10.3899/jrheum.180018. Epub 2018 Oct 1.

PMID:
30275260
9.

Haematopoietic stem cell transplantation in systemic sclerosis.

Walker UA, Saketkoo LA, Distler O.

RMD Open. 2018 Jun 17;4(1):e000533. doi: 10.1136/rmdopen-2017-000533. eCollection 2018.

10.

Feasibility, utility and symptom impact of modified mindfulness training in sarcoidosis.

Saketkoo LA, Karpinski A, Young J, Adell R, Walker M, Hennebury T, Wickremasinghe M, Russell AM.

ERJ Open Res. 2018 May 8;4(2). pii: 00085-2017. doi: 10.1183/23120541.00085-2017. eCollection 2018 Apr.

11.

Brief Report: Whole-Exome Sequencing to Identify Rare Variants and Gene Networks That Increase Susceptibility to Scleroderma in African Americans.

Gourh P, Remmers EF, Boyden SE, Alexander T, Morgan ND, Shah AA, Mayes MD, Doumatey A, Bentley AR, Shriner D, Domsic RT, Medsger TA Jr, Steen VD, Ramos PS, Silver RM, Korman B, Varga J, Schiopu E, Khanna D, Hsu V, Gordon JK, Saketkoo LA, Gladue H, Kron B, Criswell LA, Derk CT, Bridges SL Jr, Shanmugam VK, Kolstad KD, Chung L, Jan R, Bernstein EJ, Goldberg A, Trojanowski M, Kafaja S, Maksimowicz-McKinnon KM, Mullikin JC, Adeyemo A, Rotimi C, Boin F, Kastner DL, Wigley FM.

Arthritis Rheumatol. 2018 Oct;70(10):1654-1660. doi: 10.1002/art.40541. Epub 2018 Aug 29.

PMID:
29732714
12.

Qualitative Methods to Advance Care, Diagnosis, and Therapy in Rheumatic Diseases.

Saketkoo LA, Pauling JD.

Rheum Dis Clin North Am. 2018 May;44(2):267-284. doi: 10.1016/j.rdc.2018.01.004. Epub 2018 Feb 21. Review.

13.

Multidimensional fatigue in pulmonary hypertension: prevalence, severity and predictors.

Tartavoulle TM, Karpinski AC, Aubin A, Kluger BM, Distler O, Saketkoo LA.

ERJ Open Res. 2018 Mar 23;4(1). pii: 00079-2017. doi: 10.1183/23120541.00079-2017. eCollection 2018 Jan.

14.

The patient experience of Raynaud's phenomenon in systemic sclerosis.

Pauling JD, Saketkoo LA, Matucci-Cerinic M, Ingegnoli F, Khanna D.

Rheumatology (Oxford). 2019 Jan 1;58(1):18-26. doi: 10.1093/rheumatology/key026.

PMID:
29538754
15.

Patient Perceptions of the Raynaud's Condition Score Diary Provide Insight Into Its Performance in Clinical Trials of Raynaud's Phenomenon: Comment on the Article by Denton et al.

Pauling JD, Saketkoo LA, Domsic RT.

Arthritis Rheumatol. 2018 Jun;70(6):973-974. doi: 10.1002/art.40481. Epub 2018 Apr 29. No abstract available.

16.

Successful Trial Design and Planning in Systemic Sclerosis: Does It Take a Village?

Saketkoo LA.

J Rheumatol. 2018 Mar;45(3):297-299. doi: 10.3899/jrheum.180062. No abstract available.

PMID:
29496914
17.

Multinational Qualitative Research Study Exploring the Patient Experience of Raynaud's Phenomenon in Systemic Sclerosis.

Pauling JD, Domsic RT, Saketkoo LA, Almeida C, Withey J, Jay H, Frech TM, Ingegnoli F, Dures E, Robson J, McHugh NJ, Herrick AL, Matucci-Cerinic M, Khanna D, Hewlett S.

Arthritis Care Res (Hoboken). 2018 Sep;70(9):1373-1384. doi: 10.1002/acr.23475. Epub 2018 Aug 16.

18.

Changes in hemodynamic classification over time are common in systemic sclerosis-associated pulmonary hypertension: insights from the PHAROS cohort.

Lammi MR, Saketkoo LA, Gordon JK, Steen VD.

Pulm Circ. 2018 Apr-Jun;8(2):2045893218757404. doi: 10.1177/2045893218757404.

19.

Clinical and serological features of systemic sclerosis in a multicenter African American cohort: Analysis of the genome research in African American scleroderma patients clinical database.

Morgan ND, Shah AA, Mayes MD, Domsic RT, Medsger TA Jr, Steen VD, Varga J, Carns M, Ramos PS, Silver RM, Schiopu E, Khanna D, Hsu V, Gordon JK, Gladue H, Saketkoo LA, Criswell LA, Derk CT, Trojanowski MA, Shanmugam VK, Chung L, Valenzuela A, Jan R, Goldberg A, Remmers EF, Kastner DL, Wigley FM, Gourh P, Boin F.

Medicine (Baltimore). 2017 Dec;96(51):e8980. doi: 10.1097/MD.0000000000008980.

20.

Wildflowers abundant in the garden of systemic sclerosis research, while hopeful exotics will one day bloom.

Saketkoo LA.

Rheumatology (Oxford). 2018 Mar 1;57(3):410-413. doi: 10.1093/rheumatology/kex420. No abstract available.

21.

There is a need for new systemic sclerosis subset criteria. A content analytic approach.

Johnson SR, Soowamber ML, Fransen J, Khanna D, Van Den Hoogen F, Baron M, Matucci-Cerinic M, Denton CP, Medsger TA Jr, Carreira PE, Riemekasten G, Distler J, Gabrielli A, Steen V, Chung L, Silver R, Varga J, Müller-Ladner U, Vonk MC, Walker UA, Wollheim FA, Herrick A, Furst DE, Czirjak L, Kowal-Bielecka O, Del Galdo F, Cutolo M, Hunzelmann N, Murray CD, Foeldvari I, Mouthon L, Damjanov N, Kahaleh B, Frech T, Assassi S, Saketkoo LA, Pope JE.

Scand J Rheumatol. 2018 Jan;47(1):62-70. doi: 10.1080/03009742.2017.1299793. Epub 2017 Oct 9.

PMID:
28990485
22.

Timing of onset affects arthritis presentation pattern in antisyntethase syndrome.

González-Gay MA, Montecucco C, Selva-O'Callaghan A, Trallero-Araguas E, Molberg O, Andersson H, Rojas-Serrano J, Perez-Roman DI, Bauhammer J, Fiehn C, Neri R, Barsotti S, Lorenz HM, Doria A, Ghirardello A, Iannone F, Giannini M, Franceschini F, Cavazzana I, Triantafyllias K, Benucci M, Infantino M, Manfredi M, Conti F, Schwarting A, Sebastiani G, Iuliano A, Emmi G, Silvestri E, Govoni M, Scirè CA, Furini F, Lopez-Longo FJ, Martínez-Barrio J, Sebastiani M, Manfredi A, Bachiller-Corral J, Sifuentes Giraldo WA, Cimmino MA, Cosso C, Belotti Masserini A, Cagnotto G, Codullo V, Romano M, Paolazzi G, Pellerito R, Saketkoo LA, Ortego-Centeno N, Quartuccio L, Batticciotto A, Bartoloni Bocci E, Gerli R, Specker C, Bravi E, Selmi C, Parisi S, Salaffi F, Meloni F, Marchioni E, Pesci A, Dei G, Confalonieri M, Tomietto P, Nuno L, Bonella F, Pipitone N, Mera-Valera A, Perez-Gomez N, Gerzeli S, Lopez-Mejias R, Matos-Costa CJ, Pereira da Silva JA, Cifrian J, Alpini C, Olivieri I, Blázquez Cañamero MÁ, Rodriguez Cambrón AB, Castañeda S, Cavagna L; AENEAS (American and European NEtwork of Antisynthetase Syndrome) collaborative group.

Clin Exp Rheumatol. 2018 Jan-Feb;36(1):44-49. Epub 2017 Jul 26.

23.

Clinical characteristics and survival of systemic sclerosis patients with pulmonary hypertension and elevated wedge pressure: Observations from the PHAROS cohort.

Lammi MR, Saketkoo LA, Gordon JK, Lauto P, Fagan K, Steen VD; PHAROS Investigators.

Respirology. 2017 Oct;22(7):1386-1392. doi: 10.1111/resp.13067. Epub 2017 May 12.

24.

Repository corticotropin for Chronic Pulmonary Sarcoidosis.

Baughman RP, Sweiss N, Keijsers R, Birring SS, Shipley R, Saketkoo LA, Lower EE.

Lung. 2017 Jun;195(3):313-322. doi: 10.1007/s00408-017-9994-4. Epub 2017 Mar 28.

25.

Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study.

Bartoloni E, Gonzalez-Gay MA, Scirè C, Castaneda S, Gerli R, Lopez-Longo FJ, Martinez-Barrio J, Govoni M, Furini F, Pina T, Iannone F, Giannini M, Nuño L, Quartuccio L, Ortego-Centeno N, Alunno A, Specker C, Montecucco C, Triantafyllias K, Balduzzi S, Sifuentes-Giraldo WA, Paolazzi G, Bravi E, Schwarting A, Pellerito R, Russo A, Selmi C, Saketkoo LA, Fusaro E, Parisi S, Pipitone N, Franceschini F, Cavazzana I, Neri R, Barsotti S, Codullo V, Cavagna L.

Autoimmun Rev. 2017 Mar;16(3):253-257. doi: 10.1016/j.autrev.2017.01.008. Epub 2017 Jan 29. Review.

PMID:
28147261
26.

Management of extrapulmonary sarcoidosis: challenges and solutions.

Al-Kofahi K, Korsten P, Ascoli C, Virupannavar S, Mirsaeidi M, Chang I, Qaqish N, Saketkoo LA, Baughman RP, Sweiss NJ.

Ther Clin Risk Manag. 2016 Nov 7;12:1623-1634. eCollection 2016. Review.

27.

Reliance on Pulmonary Function Tests in Assessment of Systemic Sclerosis Patients for Pulmonary Hypertension: Comment on the Article by Antoniou et al.

Saketkoo LA, Steen VD, Lammi MR.

Arthritis Rheumatol. 2017 Jan;69(1):239-240. doi: 10.1002/art.39928. No abstract available.

28.

Physical activity and training in sarcoidosis: review and experience-based recommendations.

Strookappe B, Saketkoo LA, Elfferich M, Holland A, De Vries J, Knevel T, Drent M.

Expert Rev Respir Med. 2016 Oct;10(10):1057-68. doi: 10.1080/17476348.2016.1227244. Epub 2016 Sep 8. Review.

PMID:
27552344
29.

SYSTEMIC SCLEROSIS RELATED CALCINOSIS: PATIENTS PROVIDE WHAT SPECIALISTS WANT TO LEARN.

Christensen A, Khalique S, Cenac S, Fligelstone K, Mawdsley A, French T, Gordon JK, Baron M, Busman E, Steen VD, Saketkoo LA.

J La State Med Soc. 2015 May-Jun;167(3):158-9. Epub 2015 Jun 15.

PMID:
27159488
30.

THE ACHES THAT TAKE YOUR BREATH (AND TEARS) AWAY.

Becerril J, Gonzales H, Saketkoo LA.

J La State Med Soc. 2015 May-Jun;167(3):154-5. Epub 2015 Jun 15.

PMID:
27159479
31.

Biologic therapies in the treatment of sarcoidosis.

Saketkoo LA, Baughman RP.

Expert Rev Clin Immunol. 2016 Aug;12(8):817-25. doi: 10.1080/1744666X.2016.1175301. Epub 2016 May 3. Review.

PMID:
27117719
32.

Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group.

Cavagna L, Nuño L, Scirè CA, Govoni M, Longo FJ, Franceschini F, Neri R, Castañeda S, Sifuentes Giraldo WA, Caporali R, Iannone F, Fusaro E, Paolazzi G, Pellerito R, Schwarting A, Saketkoo LA, Ortego-Centeno N, Quartuccio L, Bartoloni E, Specker C, Pina Murcia T, La Corte R, Furini F, Foschi V, Bachiller Corral J, Airò P, Cavazzana I, Martínez-Barrio J, Hinojosa M, Giannini M, Barsotti S, Menke J, Triantafyllias K, Vitetta R, Russo A, Bogliolo L, Bajocchi G, Bravi E, Barausse G, Bortolotti R, Selmi C, Parisi S, Salaffi F, Montecucco C, González-Gay MA; AENEAS (American and European NEtwork of Antisynthetase Syndrome) Collaborative Group.

Clin Rev Allergy Immunol. 2017 Feb;52(1):71-80. doi: 10.1007/s12016-016-8528-9. Review.

PMID:
26782036
33.

Patient Perspectives in OMERACT Provide an Anchor for Future Metric Development and Improved Approaches to Healthcare Delivery in Connective Tissue Disease Related Interstitial Lung Disease (CTD-ILD).

Mittoo S, Frankel S, LeSage D, Strand V, Shah AA, Christopher-Stine L, Danoff S, Hummers LK, Swigris JJ, Huscher D, Christensen AM, Cenac SL, Erbil JK, Ferguson S, Garcia-Valladares I, Grewal HK, Orbai AM, Smith KC, Tran M, Bingham CO 3rd, Castelino FV, Fischer A, Saketkoo LA.

Curr Respir Med Rev. 2015 Jun;11(2):175-183.

34.

Association Between Initial Oral Therapy and Outcomes in Systemic Sclerosis-Related Pulmonary Arterial Hypertension.

Lammi MR, Mathai SC, Saketkoo LA, Domsic RT, Bojanowski C, Furst DE, Steen VD; Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Investigators.

Arthritis Rheumatol. 2016 Mar;68(3):740-8. doi: 10.1002/art.39478.

35.

Cigarette smoking and male sex are independent and age concomitant risk factors for the development of ocular sarcoidosis in a New Orleans sarcoidosis population.

Janot AC, Huscher D, Walker M, Grewal HK, Yu M, Lammi MR, Saketkoo LA.

Sarcoidosis Vasc Diffuse Lung Dis. 2015 Jul 22;32(2):138-43.

36.

Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter Study.

Cavagna L, Nuño L, Scirè CA, Govoni M, Longo FJ, Franceschini F, Neri R, Castañeda S, Sifuentes Giraldo WA, Caporali R, Iannone F, Fusaro E, Paolazzi G, Pellerito R, Schwarting A, Saketkoo LA, Ortego-Centeno N, Quartuccio L, Bartoloni E, Specker C, Murcia TP, La Corte R, Furini F, Foschi V, Corral JB, Airò P, Cavazzana I, Martínez-Barrio J, Hinojosa M, Giannini M, Barsotti S, Menke J, Triantafyllias K, Vitetta R, Russo A, Bajocchi G, Bravi E, Barausse G, Bortolotti R, Selmi C, Parisi S, Montecucco C, González-Gay MA; AENEAS (American, European NEtwork of Antisynthetase Syndrome) collaborative group.

Medicine (Baltimore). 2015 Aug;94(32):e1144. doi: 10.1097/MD.0000000000001144.

37.

Clinical trials in pulmonary sarcoidosis.

Baughman RP, Lower EE, Saketkoo LA.

Curr Opin Pulm Med. 2015 Sep;21(5):525-31. doi: 10.1097/MCP.0000000000000193. Review.

PMID:
26176971
38.

Outcome Measures for Clinical Trials in Interstitial Lung Diseases.

Lammi MR, Baughman RP, Birring SS, Russell AM, Ryu JH, Scholand M, Distler O, LeSage D, Sarver C, Antoniou K, Highland KB, Kowal-Bielecka O, Lasky JA, Wells AU, Saketkoo LA.

Curr Respir Med Rev. 2015;11(2):163-174.

39.

Biotechnological drugs: the breakthrough in autoimmune rheumatic conditions.

Cavagna L, Saketkoo LA, Schwarting A, Caporali R.

Biomed Res Int. 2014;2014:481973. doi: 10.1155/2014/481973. Epub 2014 Aug 10. No abstract available.

40.

Clinical case of the month: a 44-year-old woman with jaundice and abdominal pain.

Guillory SG, Jordan MD, Spieler BM, Safley ML, Hutchings JJ, Saketkoo LA, Lopez FA.

J La State Med Soc. 2014 May-Jun;166(3):129-33. Epub 2014 Jun 10. No abstract available.

PMID:
25075732
41.

Updating the OMERACT filter: core areas as a basis for defining core outcome sets.

Kirwan JR, Boers M, Hewlett S, Beaton D, Bingham CO 3rd, Choy E, Conaghan PG, D'Agostino MA, Dougados M, Furst DE, Guillemin F, Gossec L, van der Heijde DM, Kloppenburg M, Kvien TK, Landewé RB, Mackie SL, Matteson EL, Mease PJ, Merkel PA, Ostergaard M, Saketkoo LA, Simon L, Singh JA, Strand V, Tugwell P.

J Rheumatol. 2014 May;41(5):994-9. doi: 10.3899/jrheum.131309. Epub 2014 Mar 15.

42.

Reconciling healthcare professional and patient perspectives in the development of disease activity and response criteria in connective tissue disease-related interstitial lung diseases.

Saketkoo LA, Mittoo S, Frankel S, LeSage D, Sarver C, Phillips K, Strand V, Matteson EL; OMERACT Connective Tissue Disease–Interstitial Lung Diseases Working Group; OMERACT Connective Tissue Disease-Interstitial Lung Diseases Working Group.

J Rheumatol. 2014 Apr;41(4):792-8. doi: 10.3899/jrheum.131251. Epub 2014 Feb 1. Review.

43.

Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials.

Saketkoo LA, Mittoo S, Huscher D, Khanna D, Dellaripa PF, Distler O, Flaherty KR, Frankel S, Oddis CV, Denton CP, Fischer A, Kowal-Bielecka OM, LeSage D, Merkel PA, Phillips K, Pittrow D, Swigris J, Antoniou K, Baughman RP, Castelino FV, Christmann RB, Christopher-Stine L, Collard HR, Cottin V, Danoff S, Highland KB, Hummers L, Shah AA, Kim DS, Lynch DA, Miller FW, Proudman SM, Richeldi L, Ryu JH, Sandorfi N, Sarver C, Wells AU, Strand V, Matteson EL, Brown KK, Seibold JR; CTD-ILD Special Interest Group.

Thorax. 2014 May;69(5):428-36. doi: 10.1136/thoraxjnl-2013-204202. Epub 2013 Dec 24. Erratum in: Thorax. 2014 Sep;69(9):834. CTD-ILD Special Interest Group [added]; multiple investigator names added.

44.

The primary care physician in the early diagnosis of systemic sclerosis: the cornerstone of recognition and hope.

Saketkoo LA, Magnus JH, Doyle MK.

Am J Med Sci. 2014 Jan;347(1):54-63. doi: 10.1097/MAJ.0b013e3182a55d24. Review.

45.

Is there evidence for vasculitis in systemic sclerosis?

Saketkoo LA, Distler O.

Curr Rheumatol Rep. 2012 Dec;14(6):516-25. doi: 10.1007/s11926-012-0296-9. Review.

PMID:
23065452
46.

International Classification of Functioning, Disability and Health Core Set construction in systemic sclerosis and other rheumatic diseases: a EUSTAR initiative.

Saketkoo LA, Escorpizo R, Keen KJ, Fligelstone K, Distler O; EUSTAR.

Rheumatology (Oxford). 2012 Dec;51(12):2170-6. doi: 10.1093/rheumatology/kes185. Epub 2012 Aug 23. Review.

PMID:
22919048
47.

Central nervous system involvement including visual loss in a patient with systemic lupus erythematosus with posterior reversible leukoencephalopathy syndrome.

Grewal HK, Saketkoo LA, Garcia-Valladares I, Espinoza LR.

J Clin Rheumatol. 2012 Aug;18(5):263-4. doi: 10.1097/RHU.0b013e318262249b. No abstract available.

PMID:
22832293
48.

Axial gout: cinderella of gouty arthropathy!

Saketkoo LA, Garcia-Valladares I, Espinoza LR.

J Rheumatol. 2012 Jul;39(7):1314-6. doi: 10.3899/jrheum.120375. No abstract available.

PMID:
22753798
49.

Developing disease activity and response criteria in connective tissue disease-related interstitial lung disease.

Saketkoo LA, Matteson EL, Brown KK, Seibold JR, Strand V; Connective Tissue Disease-related Interstitial Lung Disease Special Interest Group.

J Rheumatol. 2011 Jul;38(7):1514-8. doi: 10.3899/jrheum.110281.

PMID:
21724725

Supplemental Content

Loading ...
Support Center